Clinical Trial Update: A Study of Psilocybin for PTSD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating psilocybin for post-traumatic stress disorder is sponsored by Johns Hopkins University. The study is currently active and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Post Traumatic Stress Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING